SuperworthExponent free cash flow EXPO
Cash from operations less capital spending, by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jul 3, 2026
- $108.6M
- Latest quarter, Q2 FY26
- $29.1M
- −14% on a year earlier
- Fiscal year 2025
- $122.3M
- −11% on the year before
Exponent's free cash flow was $108.6M over the twelve months to Jul 3, 2026, down 10% on a year earlier.
In its latest quarter, Q2 FY26, it was $29.1M, down 14% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 4% a year on average.
Free cash flow over time
Fiscal year by fiscal year
| Fiscal year | Free cash flow | Change |
|---|---|---|
| FY2025 | $122.3M | −11% |
| FY2024 | $137.6M | +24% |
| FY2023 | $111M | +36% |
| FY2022 | $81.8M | −31% |
| FY2021 | $117.7M | +20% |
| FY2020 | $98.3M | +16% |
| FY2019 | $85M | +14% |
| FY2018 | $74.9M | +19% |
| FY2017 | $63.1M | +20% |
| FY2016 | $52.6M | −5% |
| FY2015 | $55.1M | +27% |
| FY2014 | $43.3M | −1% |
| FY2012 | $43.6M | n/a |
| FY2011 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | Free cash flow | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $29.1M | −14% | $108.6M | |
| Q1 FY26 | −$3.4M | −162% | $113.4M | |
| Q4 FY25 | $52.9M | −1% | $122.3M | |
| Q3 FY25 | $30M | +7% | $122.9M | |
| Q2 FY25 | $33.9M | −28% | $120.9M | |
| Q1 FY25 | $5.5M | −38% | $134.2M | |
| Q4 FY24 | $53.5M | −23% | $137.6M | |
| Q3 FY24 | $28M | +48% | $153.5M | |
| Q2 FY24 | $47.2M | +34% | $144.4M | |
| Q1 FY24 | $8.9M | n/a | $132.3M | |
| Q4 FY23 | $69.4M | +84% | $111M | |
| Q3 FY23 | $18.9M | −28% | $79.3M |
Against its peers
Companies in Consulting Services nearest Exponent's size, closest first, today.
| Company | Free cash flow yield |
|---|---|
| EXPOExponent | 2.9% |
| FCNFTI Consulting | 8.3% |
| HURNHuron Consulting | 5.2% |
| ASTHAstrana Health | 4.5% |
| GGenpact LTD | 8.3% |
| ICFIICF International | 11.7% |
| BAHBooz Allen Hamilton | 11.8% |
| BWMNBowman Consulting | 1.7% |
| EFXEquifax | 5.2% |
| Peer median | 6.7% |
Where Exponent ranks
What the free cash flow tells you
Cash from operations minus capital spending. The cash the company could hand back or reinvest.
Seasonal and lumpy quarter to quarter. The TTM view is the one to trust.
More on Exponent
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.